메뉴 건너뛰기




Volumn 48, Issue 8, 2008, Pages 1541-1544

Blood supply safety: An NHLBI perspective

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; EDITORIAL; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NUCLEIC ACID AMPLIFICATION; OUTCOME ASSESSMENT; RISK ASSESSMENT; SCREENING TEST; THROMBOCYTE PRESERVATION; TRANSFUSION RELATED ACUTE LUNG INJURY; VASCULARIZATION;

EID: 48249132865     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01754.x     Document Type: Editorial
Times cited : (8)

References (21)
  • 1
    • 48249141102 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: Use of an immunoassay to identify recent infections
    • Transfusion-Transmissible Agents Working Group" of the French Society of Blood Transfusion. doi: 10.1111/j.1537-2995.2008.01739.x
    • Pillonel J, Barin F, Laperche S, Bernillon P, Le Vu S, Brunet S, Thierry D, Desenclos JC Transfusion-Transmissible Agents Working Group" of the French Society of Blood Transfusion. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections. Transfusion doi: 10.1111/j.1537-2995.2008.01739. x
    • Transfusion
    • Pillonel, J.1    Barin, F.2    Laperche, S.3    Bernillon, P.4    Le Vu, S.5    Brunet, S.6    Thierry, D.7    Desenclos, J.C.8
  • 2
    • 47849104778 scopus 로고    scopus 로고
    • Experience of German Red Cross Blood donor services with nucleic acid testing: Results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus
    • German Red Cross NAT Study Group. doi: 10.1111/j.1537-2995.2008.01718.x
    • Hourfar MK, Brixner V, Busch MP, Geusendam G, Gubbe K, Jork C, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Schottstedt V, Seifried E, Weber-Schehl M, Wright DJ German Red Cross NAT Study Group. Experience of German Red Cross Blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion doi: 10.1111/j.1537-2995. 2008.01718.x
    • Transfusion
    • Hourfar, M.K.1    Brixner, V.2    Busch, M.P.3    Geusendam, G.4    Gubbe, K.5    Jork, C.6    Mahnhardt, C.7    Mayr-Wohlfart, U.8    Pichl, L.9    Roth, W.K.10    Schmidt, M.11    Schottstedt, V.12    Seifried, E.13    Weber-Schehl, M.14    Wright, D.J.15
  • 3
    • 0029942003 scopus 로고    scopus 로고
    • The risk of transfusion-transmitted viral infections. the Retrovirus Epidemiology Donor Study
    • Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996 334 : 1685 90.
    • (1996) N Engl J Med , vol.334 , pp. 1685-90
    • Schreiber, G.B.1    Busch, M.P.2    Kleinman, S.H.3    Korelitz, J.J.4
  • 4
    • 0036692181 scopus 로고    scopus 로고
    • International application of the incidence/window period model. (Editorial)
    • Glynn SA, Kleinman SH, Wright DJ, Busch MP. International application of the incidence/window period model. (Editorial). Transfusion 2002 42 : 966 72.
    • (2002) Transfusion , vol.42 , pp. 966-72
    • Glynn, S.A.1    Kleinman, S.H.2    Wright, D.J.3    Busch, M.P.4
  • 6
    • 13144297801 scopus 로고    scopus 로고
    • A new strategy for estimating risk of transfusion-transmitted viral infections based on rates of detection of recently infected donors
    • Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH. A new strategy for estimating risk of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 : 254 64.
    • (2005) Transfusion , vol.45 , pp. 254-64
    • Busch, M.P.1    Glynn, S.A.2    Stramer, S.L.3    Strong, D.M.4    Caglioti, S.5    Wright, D.J.6    Pappalardo, B.7    Kleinman, S.H.8
  • 9
    • 33745610730 scopus 로고    scopus 로고
    • Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: Implications for blood safety, diagnostics, treatment, and molecular epidemiology
    • S35.
    • Delwart E, Kuhns MC, Busch MP. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology. J Med Virol 2006 78 : S30 S35.
    • (2006) J Med Virol , vol.78
    • Delwart, E.1    Kuhns, M.C.2    Busch, M.P.3
  • 11
    • 33748951602 scopus 로고    scopus 로고
    • Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors
    • Busch MP. Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors. Transfusion 2006 46 : 1663 6.
    • (2006) Transfusion , vol.46 , pp. 1663-6
    • Busch, M.P.1
  • 13
    • 33748951788 scopus 로고    scopus 로고
    • Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands
    • Van der Bij AK, Coutinho RA, van der Poel CL. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Transfusion 2006 46 : 1729 36.
    • (2006) Transfusion , vol.46 , pp. 1729-36
    • Van Der Bij, A.K.1    Coutinho, R.A.2    Van Der Poel, C.L.3
  • 14
    • 34248336448 scopus 로고    scopus 로고
    • Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: The American Red Cross experience (2004-2006)
    • Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007 47 : 1134 42.
    • (2007) Transfusion , vol.47 , pp. 1134-42
    • Eder, A.F.1    Kennedy, J.M.2    Dy, B.A.3    Notari, E.P.4    Weiss, J.W.5    Fang, C.T.6    Wagner, S.7    Dodd, R.Y.8    Benjamin, R.J.9
  • 15
    • 48249102871 scopus 로고    scopus 로고
    • Possibilities for the future
    • NHLBI Working Group on Transfusion Recipient Epidemiology and Outcomes Research. doi: 10.1111/j.1537-2995.2008.01807.x
    • Hillyer CD, Blumberg N, Glynn SA, Ness P NHLBI Working Group on Transfusion Recipient Epidemiology and Outcomes Research. Possibilities for the future. Transfusion doi: 10.1111/j.1537-2995.2008.01807.x
    • Transfusion
    • Hillyer, C.D.1    Blumberg, N.2    Glynn, S.A.3    Ness, P.4
  • 16
    • 0343360868 scopus 로고    scopus 로고
    • A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
    • The Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group.
    • Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E The Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;1999:409-17. [Erratum, N Engl J Med 340:1056.]
    • (1999) N Engl J Med , vol.1999 , pp. 409-417
    • Hébert, P.C.1    Wells, G.2    Blajchman, M.A.3    Marshall, J.4    Martin, C.5    Pagliarello, G.6    Tweeddale, M.7    Schweitzer, I.8    Yetisir, E.9
  • 18
    • 33646367895 scopus 로고    scopus 로고
    • Pneumonia as a complication of blood product transfusion in the critically ill: Transfusion-related immunomodulation (TRIM)
    • Suppl
    • Vamvakas EC. Pneumonia as a complication of blood product transfusion in the critically ill: transfusion-related immunomodulation (TRIM). Crit Care Med 2006 34 (Suppl S151 S159.
    • (2006) Crit Care Med , vol.34
    • Vamvakas, E.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.